Life Tech Banks on qPCR to Stimulate Growth of Lackluster Molecular Biology Business | GenomeWeb

By Ben Butkus

Life Technologies this week reported flat year-over-year organic revenue growth for its Molecular Biology Systems division despite new product launches and overall growth of the company's qPCR franchise, which is part of the division, company officials said.

As such, Life Tech will primarily focus on achieving additional growth via its qPCR franchise in the coming months in an attempt to counteract the relative slowdown in the MBS division over the past several quarters, officials said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.